New Update
CO-Win 2.0: Union Health Ministry on Friday chaired a high-level meeting with Health Secretaries and MDs (NHM) of States and UTs on age-appropriate groups for COVID-19 vaccination in India.
COVID-19 Vaccination drive in India was launched on January 16, 2021. From March 1, 2021, this will be expanded to all citizens above 60 years of age, and those within the age bracket of 45 to 59 years with specified co-morbidities.
FACT CHECK: Has Punjab government announced lockdown in the state?
The States and UTs have been explained the basic features of version 2.0 of the digital platform CO-Win, which is a population-scale software with the capacity of processing several thousands of entries.
The new phase of vaccination of age-appropriate groups will expand the COVID-19 vaccination in the country manifold. With a citizen-centric approach, the fundamental shift in this phase is that citizens in the identified age groups, as also those healthcare workers and frontline who have been missed out or left out of the present phase of vaccination, can select vaccination centres of their choice.
Also Read | Coronavirus India: MHA extends existing COVID-19 guidelines
Also Read |
Secondly, the private sector hospitals will be involved as Vaccination centres to harness their potential to expand vaccination capacities.
The States and UTs have explained the simplified process of registration, which shall be through three routes:
- Advance Self-Registration: The beneficiaries will be able to self-register in advance by downloading the CO-Win 2.0 portal and through other IT Applications such as Arogya Setu etc.
- On-site Registration: Facility of On-Site registration allows those who cannot self-register in advance to walk into the identified COVID Vaccination Centres and get themselves registered on-site and then vaccinated.
- Facilitated Cohort Registration: The State/UT Government will take a proactive lead. Specific date(s) for COVID vaccination will be decided where target groups of potential beneficiates will be vaccinated.